Conduit Pharmaceuticals Inc. (NASDAQ:CDTTW) Sees Significant Increase in Short Interest

Conduit Pharmaceuticals Inc. (NASDAQ:CDTTW) was the recipient of a significant growth in short interest in the month of December. As of December 15th, there was short interest totalling 110,600 shares, a growth of 116.0% from the November 30th total of 51,200 shares. Based on an average daily trading volume, of 20,000 shares, the days-to-cover ratio is currently 5.5 days.

Conduit Pharmaceuticals Stock Performance

Shares of NASDAQ:CDTTW traded down $0.00 during mid-day trading on Friday, reaching $0.01. The stock had a trading volume of 68,594 shares, compared to its average volume of 20,992. The firm has a 50 day simple moving average of $0.01 and a two-hundred day simple moving average of $0.02. Conduit Pharmaceuticals has a twelve month low of $0.01 and a twelve month high of $0.15.

About Conduit Pharmaceuticals

Conduit Pharmaceuticals Inc, a clinical-stage specialty biopharmaceutical company, develops pharmaceutical products that provides unmet medical needs in the areas of autoimmune diseases and idiopathic male infertility. Its pipeline includes AZD1656, which has completed Phase I trials for the treatment of type 2 diabetes, renal transplant, Hashimoto's thyroiditis and Grave's disease, uveitis, and preterm labor; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility.